Drugs that were subject to Expanded and Accelerated Price Disclosure - 1 May 2014
This page lists those drugs where a brand of a pharmaceutical item was subject to Expanded and Accelerated Price Disclosure requirements and identifies the relevant price disclosure cycles for those drugs (as at the end of EAPD)..
Each cycle is identified by the year of the first reduction day after the end of its data collection period. This provides consistent naming for main and supplementary cycles and links each cycle to a time period. For example, the cycle that was known as Main Cycle 2 is the 2013 Main Cycle because the first reduction day following the end of the data collection period was 1 April 2013.
A drug and manner of administration is in a cycle with data collection in progress. The drug and manner of administration may also be in another cycle, undergoing its data processing period and awaiting a reduction day. For example, the drug and manner of administration may be in the 2015 Main Cycle for data collection and still in the 2014 Main Cycle awaiting a reduction day.
To identify the reporting periods and due dates for a manner of administration of a drug, follow the steps outlined below:
- Identify the cycle in which the drug and manner of administration is allocated; and
- Based on the cycle refer to the Procedural and Operational Guidelines (clauses 33-51) to identify data collection periods, reporting periods and submission deadlines.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W, X, Y, Z |
Drug |
Manner of Administration |
Data collection cycle in progress |
Cycle finished data collection and now awaiting reduction day |
---|---|---|---|
A | |||
Aciclovir |
Application to the eye |
2015 Main Cycle |
|
Aciclovir |
Oral |
2015 Main Cycle |
|
Acitretin |
Oral |
2015 Supplementary Cycle B |
|
Alendronic Acid |
Oral |
2015 Main Cycle |
|
Alendronic Acid with Colecalciferol |
Oral |
2015 Main Cycle |
|
Alendronic Acid with Colecalciferol and Calcium |
Oral |
2015 Main Cycle |
|
Allopurinol |
Oral |
2015 Main Cycle |
|
Alprazolam |
Oral |
2015 Main Cycle |
|
Aluminium Hydroxide with Magnesium Hydroxide |
Oral |
2015 Main Cycle |
|
Amiodarone |
Oral |
2015 Main Cycle |
|
Amisulpride |
Oral |
2015 Main Cycle |
|
Amlodipine |
Oral |
2015 Main Cycle |
|
Amlodipine with Atorvastatin |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Amlodipine with valsartan |
Oral |
2016 Main Cycle |
2014 Supplementary Cycle A |
Amlodipine with valsartan and hydrochlorothiazide |
Oral |
2016 Main Cycle |
2014 Supplementary Cycle A |
Amoxycillin |
Oral |
2015 Main Cycle |
|
Amoxycillin with Clavulanic Acid |
Oral |
2015 Main Cycle |
|
Ampicillin |
Injection |
2015 Main Cycle |
|
Anastrozole |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Aspirin |
Oral |
2015 Main Cycle |
|
Atenolol |
Oral |
2015 Main Cycle |
|
Atorvastatin |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Azathioprine |
Oral |
2015 Main Cycle |
|
Azithromycin |
Oral |
2015 Main Cycle |
|
B | |||
Baclofen |
Oral |
2015 Main Cycle |
|
Betamethasone |
Application |
2015 Main Cycle |
|
Betamethasone |
Injection |
2015 Main Cycle |
|
Betaxolol |
Application to the eye |
2015 Main Cycle |
|
Bicalutamide |
Oral |
2015 Main Cycle |
|
Bisacodyl |
Oral |
2015 Main Cycle |
|
Bisacodyl |
Rectal |
2015 Main Cycle |
|
Bisoprolol |
Oral |
2015 Main Cycle |
|
Bleomycin |
Injection |
2015 Main Cycle |
|
Brimonidine |
Application to the eye |
2015 Main Cycle |
|
Brinzolamide |
Application to the eye |
2015 Main Cycle |
|
Bromocriptine |
Oral |
2015 Main Cycle |
|
Bupropion |
Oral |
2015 Main Cycle |
|
C | |||
Cabergoline |
Oral |
2015 Main Cycle |
|
Calcitriol |
Oral |
2015 Main Cycle |
|
Candesartan |
Oral |
2014 Supplementary Cycle B |
|
Candesartan with Hydrochlorothiazide |
Oral |
2015 Main Cycle |
|
Captopril |
Oral |
2015 Main Cycle |
|
Carbamazepine |
Oral |
2015 Main Cycle |
|
Carbomer |
Application to the eye |
2015 Main Cycle |
|
Carboplatin |
Injection |
2015 Main Cycle |
|
Carvedilol |
Oral |
2015 Main Cycle |
|
Cefaclor |
Oral |
2015 Main Cycle |
|
Cefalotin |
Injection |
2015 Main Cycle |
|
Cefepime |
Injection |
2015 Main Cycle |
|
Cefotaxime |
Injection |
2015 Main Cycle |
|
Ceftriaxone |
Injection |
2015 Main Cycle |
|
Cephalexin |
Oral |
2015 Main Cycle |
|
Cephazolin |
Injection |
2015 Main Cycle |
|
Cimetidine |
Oral |
2015 Main Cycle |
|
Ciprofloxacin |
Application to the eye |
2015 Main Cycle |
|
Ciprofloxacin |
Oral |
2015 Main Cycle |
|
Cisplatin |
Injection |
2015 Main Cycle |
|
Citalopram |
Oral |
2015 Main Cycle |
|
Clarithromycin |
Oral |
2015 Main Cycle |
|
Clindamycin |
Oral |
2015 Main Cycle |
|
Clomiphene |
Oral |
2015 Main Cycle |
|
Clomipramine |
Oral |
2015 Main Cycle |
|
Clonazepam |
Oral |
2015 Main Cycle |
|
Clopidogrel |
Oral |
2015 Main Cycle |
|
Clopidogrel with Aspirin |
Oral |
2015 Main Cycle |
|
Clozapine |
Oral |
2015 Main Cycle |
|
Codeine with Paracetamol |
Oral |
2015 Main Cycle |
|
Colchicine |
Oral |
2015 Main Cycle |
|
Cromoglycic Acid |
Application to the eye |
2015 Main Cycle |
|
Cromoglycic Acid |
Inhalation by mouth |
2015 Main Cycle |
|
Cyclosporin |
Oral |
2015 Main Cycle |
|
Cyproterone |
Oral |
2015 Main Cycle |
|
D | |||
Desferrioxamine |
Injection |
2015 Main Cycle |
|
Desvenlafaxine |
Oral |
2014 Supplementary Cycle B |
|
Dexamethasone |
Application to the eye |
2015 Main Cycle (formerly 2013 Supplementary Cycle A) |
|
Dexamethasone |
Injection |
2015 Main Cycle (formerly 2013 Supplementary Cycle A) |
|
Dexamethasone |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle A) |
|
Dexamethasone with Framycetin and Gramicidin |
Application to the ear |
2015 Main Cycle |
|
Diazepam |
Oral |
2015 Main Cycle |
|
Diclofenac |
Oral |
2015 Main Cycle |
|
Dicloxacillin |
Oral |
2015 Main Cycle |
|
Digoxin |
Oral |
2015 Main Cycle |
|
Diltiazem |
Oral |
2015 Main Cycle |
|
Diphenoxylate with Atropine |
Oral |
2015 Main Cycle |
|
Docetaxel |
Injection |
2015 Main Cycle |
|
Donepezil |
Oral |
2014 Supplementary Cycle B |
|
Dothiepin |
Oral |
2015 Main Cycle |
|
Doxorubicin |
Injection/intravesical |
2015 Main Cycle |
|
Doxorubicin - Peglyated Liposomal |
Injection |
2015 Supplementary Cycle B |
|
Doxycycline |
Oral |
2015 Main Cycle |
|
Duloxetine |
Oral |
2014 Supplementary Cycle B |
|
E | |||
Electrolyte Replacement, Oral |
Oral |
2015 Main Cycle |
|
Enalapril |
Oral |
2015 Main Cycle |
|
Enalapril with Hydrochlorothiazide |
Oral |
2015 Main Cycle |
|
Epirubicin |
Injection/intravesical |
2015 Main Cycle |
|
Eprosartan |
Oral |
2014 Supplementary Cycle B |
|
Erythromycin |
Oral |
2015 Main Cycle |
|
Escitalopram |
Oral |
2015 Main Cycle |
|
Esomeprazole |
Oral |
2015 Main Cycle |
|
Etoposide |
Injection |
2015 Main Cycle |
|
Etoposide |
Oral |
2015 Main Cycle |
|
Exemestane |
Oral |
2015 Main Cycle |
|
F | |||
Famciclovir |
Oral |
2015 Main Cycle |
|
Famotidine |
Oral |
2015 Main Cycle |
|
Felodipine |
Oral |
2015 Main Cycle |
|
Fentanyl |
Buccal |
2015 Main Cycle |
|
Fentanyl |
Transdermal |
2015 Main Cycle |
|
Filgrastim |
Injection |
2015 Main Cycle |
|
Flecainide |
Oral |
2015 Main Cycle |
|
Flucloxacillin |
Injection |
2015 Main Cycle |
|
Flucloxacillin |
Oral |
2015 Main Cycle |
|
Fluconazole |
Injection |
2015 Main Cycle |
|
Fluconazole |
Oral |
2015 Main Cycle |
|
Fludarabine |
Injection |
2015 Main Cycle |
|
Fludarabine |
Oral |
2015 Main Cycle |
|
Fluorouracil |
Injection |
2015 Main Cycle |
|
Fluoxetine |
Oral |
2015 Main Cycle |
|
Flutamide |
Oral |
2015 Main Cycle |
|
Fluvastatin |
Oral |
2015 Main Cycle |
|
Fluvoxamine |
Oral |
2015 Main Cycle |
|
Folinic acid |
Oral |
2015 Main Cycle |
|
Folinic acid |
Injection |
2015 Main Cycle |
|
Fosinopril |
Oral |
2015 Main Cycle |
|
Fosinopril with Hydrochlorothiazide |
Oral |
2015 Main Cycle |
|
Frusemide |
Injection |
2015 Main Cycle |
|
Frusemide |
Oral |
2015 Main Cycle |
|
G | |||
Gabapentin |
Oral |
2015 Main Cycle |
|
Galantamine |
Oral |
2015 Main Cycle |
|
Gemcitabine |
Injection |
2015 Main Cycle |
|
Gemfibrozil |
Oral |
2015 Main Cycle |
|
Gentamicin |
Application to the eye |
2015 Main Cycle |
|
Gentamicin |
Injection |
2015 Main Cycle |
|
Glibenclamide |
Oral |
2015 Main Cycle |
|
Gliclazide |
Oral |
2015 Main Cycle |
|
Glimepiride |
Oral |
2015 Main Cycle |
|
Glipizide |
Oral |
2015 Main Cycle |
|
Glucose |
Injection |
2015 Main Cycle |
|
Glyceryl Trinitrate |
Buccal/sublingual |
2015 Main Cycle |
|
Glyceryl Trinitrate |
Transdermal |
2015 Main Cycle |
|
Granisetron |
Injection |
2015 Main Cycle |
|
Granisetron |
Oral |
2015 Main Cycle |
|
H | |||
Hydrochlorothiazide with Amiloride |
Oral |
2015 Main Cycle |
|
Hydrocortisone |
Application |
2015 Main Cycle |
|
Hydrocortisone |
Application to the eye |
2015 Main Cycle |
|
Hydrocortisone |
Injection |
2015 Main Cycle |
|
Hydrocortisone |
Oral |
2015 Main Cycle |
|
Hydrocortisone |
Rectal |
2015 Main Cycle |
|
Hydroxocobalamin |
Injection |
2015 Main Cycle |
|
Hydroxychloroquine |
Oral |
2015 Main Cycle |
|
Hypromellose |
Application to the eye |
2015 Main Cycle |
|
Hypromellose |
Oral application |
2015 Main Cycle |
|
Hypromellose with Carbomer 980 |
Application to the eye |
2015 Main Cycle |
|
Hypromellose with Dextran |
Application to the eye |
2015 Main Cycle |
|
I | |||
Idarubicin |
Injection |
2015 Main Cycle |
|
Idarubicin |
Oral |
2015 Main Cycle |
|
Imipramine |
Oral |
2015 Main Cycle |
|
Imiquimod |
Application |
2016 Main Cycle |
2014 Supplementary Cycle A |
Indapamide |
Oral |
2015 Main Cycle |
|
Indomethacin |
Oral |
2015 Main Cycle |
|
Interferon beta-1b |
Injection |
2014 Supplementary Cycle B |
|
Ipratropium |
Inhalation |
2015 Main Cycle |
|
Ipratropium |
Inhalation by mouth |
2015 Main Cycle |
|
Irbesartan |
Oral |
2014 Supplementary Cycle B |
|
Irbesartan with Hydrochlorothiazide |
Oral |
2014 Supplementary Cycle B |
|
Irinotecan |
Injection |
2015 Main Cycle |
|
Iron Polymaltose Complex |
Injection |
2015 Main Cycle |
|
Isosorbide Dinitrate |
Oral |
2015 Main Cycle |
|
Isosorbide Mononitrate |
Oral |
2015 Main Cycle |
|
Isotretinoin |
Oral |
2015 Main Cycle |
|
J | |||
K | |||
Ketoprofen |
Oral |
2015 Main Cycle |
|
L | |||
Labetalol |
Oral |
2015 Main Cycle |
|
Lactulose |
Oral |
2015 Main Cycle |
|
Lamivudine |
Oral |
2015 Main Cycle |
|
Lamivudine with Zidovudine |
Oral |
2015 Main Cycle |
|
Lamotrigine |
Oral |
2015 Main Cycle |
|
Lansoprazole |
Oral |
2015 Main Cycle |
|
Latanoprost |
Application to the eye |
2015 Main Cycle |
|
Latanoprost with timolol |
Application to the eye |
2015 Main Cycle |
|
Leflunomide |
Oral |
2015 Main Cycle |
|
Lercanidipine |
Oral |
2015 Main Cycle |
|
Letrozole |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Levetiracetam |
Oral |
2015 Main Cycle |
|
Levodopa with Carbidopa |
Intra-intestinal |
2015 Main Cycle |
|
Levodopa with Carbidopa |
Oral |
2015 Main Cycle |
|
Levonorgestrel with Ethinyloestradiol |
Oral |
2015 Main Cycle |
|
Lisinopril |
Oral |
2015 Main Cycle |
|
Loperamide |
Oral |
2015 Main Cycle |
|
Losartan |
Oral |
2014 Supplementary Cycle B |
Drug |
Manner of Administration |
Data collection cycle in progress |
Cycle finished data collection and now awaiting reduction day |
---|---|---|---|
M | |||
Macrogol 3350 |
Oral |
2015 Main Cycle |
|
Medroxyprogesterone |
Injection |
2015 Main Cycle |
|
Medroxyprogesterone |
Oral |
2015 Main Cycle |
|
Meloxicam |
Oral |
2015 Main Cycle |
|
Memantine |
Oral |
2015 Main Cycle |
|
Metformin |
Oral |
2015 Main Cycle |
|
Methadone |
Oral |
2015 Main Cycle |
|
Methotrexate |
Injection |
2015 Main Cycle |
|
Methotrexate |
Oral |
2015 Main Cycle |
|
Methyldopa |
Oral |
2015 Main Cycle |
|
Methylphenidate |
Oral |
2015 Main Cycle |
|
Methylprednisolone |
Application |
2015 Main Cycle |
|
Methylprednisolone |
Injection |
2015 Main Cycle |
|
Metoclopramide |
Oral |
2015 Supplementary Cycle B |
|
Metoclopramide |
Injection |
2015 Supplementary Cycle B |
|
Metoprolol |
Oral |
2015 Main Cycle |
|
Metronidazole |
Injection |
2015 Main Cycle |
|
Metronidazole |
Oral |
2015 Main Cycle |
|
Mianserin |
Oral |
2015 Main Cycle |
|
Minocycline |
Oral |
2015 Main Cycle |
|
Mirtazapine |
Oral |
2015 Main Cycle |
|
Misoprostol |
Oral |
2015 Main Cycle |
|
Mitozantrone |
Injection |
2015 Main Cycle |
|
Moclobemide |
Oral |
2015 Main Cycle |
|
Mometasone |
Application |
2015 Main Cycle |
|
Montelukast |
Oral |
2015 Main Cycle |
|
Morphine |
Injection |
2015 Main Cycle |
|
Morphine |
Oral |
2015 Main Cycle |
|
Mycophenolic acid |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
N | |||
Naltrexone |
Oral |
2015 Main Cycle |
|
Naproxen |
Oral |
2015 Main Cycle |
|
Nevirapine |
Oral |
2016 Main Cycle |
2014 Supplementary Cycle A |
Nifedipine |
Oral |
2015 Main Cycle |
|
Nitrazepam |
Oral |
2015 Main Cycle |
|
Nizatidine |
Oral |
2015 Main Cycle |
|
Norethisterone |
Oral |
2015 Main Cycle |
|
Norethisterone with Ethinyloestradiol |
Oral |
2015 Main Cycle |
|
Norfloxacin |
Oral |
2015 Main Cycle |
|
O | |||
Octreotide |
Injection |
2015 Main Cycle |
|
Oestradiol |
Oral |
2015 Main Cycle |
|
Oestradiol |
Transdermal |
2015 Main Cycle |
|
Olanzapine |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Olanzapine |
Injection |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Olmesartan |
Oral |
2014 Supplementary Cycle B |
|
Omeprazole |
Oral |
2015 Main Cycle |
|
Omeprazole and Clarithromycin and Amoxycillin |
Oral |
2015 Main Cycle |
|
Ondansetron |
Injection |
2015 Main Cycle |
|
Ondansetron |
Oral |
2015 Main Cycle |
|
Oxaliplatin |
Injection |
2015 Main Cycle |
|
Oxazepam |
Oral |
2015 Main Cycle |
|
Oxybutynin |
Oral |
2015 Main Cycle |
|
Oxybutynin |
Transdermal |
2015 Main Cycle |
|
P | |||
Paclitaxel |
Injection |
2015 Main Cycle |
|
Pamidronic Acid |
Injection |
2015 Main Cycle |
|
Pantoprazole |
Oral |
2015 Main Cycle |
|
Paracetamol |
Oral |
2015 Main Cycle |
|
Paraffin |
Application to the eye |
2015 Main Cycle |
|
Paroxetine |
Oral |
2015 Main Cycle |
|
Perindopril |
Oral |
2015 Main Cycle |
|
Perindopril with Amlodipine |
Oral |
2015 Main Cycle |
|
Perindopril with Indapamide |
Oral |
2015 Main Cycle |
|
Phenoxymethylpenicillin |
Oral |
2015 Main Cycle |
|
Pilocarpine |
Application to the eye |
2015 Main Cycle |
|
Pindolol |
Oral |
2015 Main Cycle |
|
Pioglitazone |
Oral |
2015 Main Cycle |
|
Piroxicam |
Oral |
2015 Main Cycle |
|
Polyvinyl Alcohol |
Application to the eye |
2015 Main Cycle |
|
Potassium Chloride |
Oral |
2015 Main Cycle |
|
Potassium Chloride with Potassium Bicarbonate |
Oral |
2015 Main Cycle |
|
Pramipexole |
Oral |
2015 Main Cycle |
|
Pravastatin |
Oral |
2015 Main Cycle |
|
Prazosin |
Oral |
2015 Main Cycle |
|
Prednisolone |
Oral |
2015 Main Cycle |
|
Prednisolone |
Rectal |
2015 Main Cycle |
|
Prednisone |
Oral |
2015 Main Cycle |
|
Prochlorperazine |
Oral |
2015 Main Cycle |
|
Q | |||
Quetiapine |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Quinapril |
Oral |
2015 Main Cycle |
|
Quinine |
Oral |
2015 Main Cycle |
|
R | |||
Rabeprazole |
Oral |
2015 Main Cycle |
|
Ramipril |
Oral |
2015 Main Cycle |
|
Ranitidine |
Oral |
2015 Main Cycle |
|
Riluzole |
Oral |
2016 Main Cycle |
2014 Supplementary Cycle A |
Risedronic Acid |
Oral |
2015 Main Cycle |
|
Risedronic Acid and Calcium |
Oral |
2015 Main Cycle |
|
Risedronic Acid and Calcium with Colecalciferol |
Oral |
2015 Main Cycle |
|
Risperidone |
Injection |
2015 Main Cycle |
|
Risperidone |
Oral |
2015 Main Cycle |
|
Rosuvastatin |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Roxithromycin |
Oral |
2015 Main Cycle |
|
S | |||
Salbutamol |
Inhalation |
2015 Main Cycle |
|
Salbutamol |
Inhalation by mouth |
2015 Main Cycle |
|
Selegiline |
Oral |
2015 Main Cycle |
|
Sertraline |
Oral |
2015 Main Cycle |
|
Simvastatin |
Oral |
2015 Main Cycle |
|
Sodium Chloride |
Injection |
2015 Main Cycle |
|
Sodium Lactate Compound |
Injection |
2015 Main Cycle |
|
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate |
Rectal |
2015 Main Cycle |
|
Sotalol |
Oral |
2015 Main Cycle |
|
Spironolactone |
Oral |
2015 Main Cycle |
|
Sucralfate |
Oral |
2015 Main Cycle |
|
Sulfasalazine |
Oral |
2015 Main Cycle |
|
Sumatriptan |
Nasal |
2015 Main Cycle |
|
Sumatriptan |
Oral |
2015 Main Cycle |
|
T | |||
Tacrolimus |
Oral |
2015 Main Cycle |
|
Tamoxifen |
Oral |
2015 Main Cycle |
|
Telmisartan |
Oral |
2014 Supplementary Cycle B |
|
Telmisartan with Hydrochlorothiazide |
Oral |
2015 Main Cycle |
|
Temazepam |
Oral |
2015 Main Cycle |
|
Temozolomide |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle A) |
|
Terbinafine |
Oral |
2015 Main Cycle |
|
Thyroxine |
Oral |
2015 Main Cycle |
|
Ticlopidine |
Oral |
2015 Main Cycle |
|
Timolol |
Application to the eye |
2015 Main Cycle |
|
Tinidazole |
Oral |
2015 Main Cycle |
|
Topiramate |
Oral |
2015 Main Cycle |
|
Topotecan |
Injection |
2015 Main Cycle |
|
Tramadol |
Injection |
2015 Main Cycle |
|
Tramadol |
Oral |
2015 Main Cycle |
|
Trandolapril |
Oral |
2015 Main Cycle |
|
Triamcinolone |
Application |
2015 Main Cycle |
|
Triamcinolone |
Injection |
2015 Main Cycle |
|
Triamcinolone with Neomycin, Gramicidin and Nystatin |
Application to the ear |
2015 Main Cycle |
|
Trimethoprim |
Oral |
2015 Main Cycle |
|
Trimethoprim with Sulfamethoxazole |
Oral |
2015 Main Cycle |
|
Tropisetron |
Oral |
2014 Supplementary Cycle B |
|
Tropisetron |
Injection |
2014 Supplementary Cycle B |
|
U | |||
V | |||
Valaciclovir |
Oral |
2015 Main Cycle |
|
Valproic Acid |
Oral |
2015 Main Cycle |
|
Valsartan |
Oral |
2014 Supplementary Cycle B |
|
Vancomycin |
Injection |
2015 Main Cycle |
|
Vancomycin |
Oral |
2015 Main Cycle |
|
Venlafaxine |
Oral |
2015 Main Cycle (formerly 2013 Supplementary Cycle B) |
|
Verapamil |
Oral |
2015 Main Cycle |
|
Vincristine |
Injection |
2015 Main Cycle |
|
Vinorelbine |
Injection |
2015 Main Cycle |
|
Vinorelbine |
Oral |
2015 Main Cycle |
|
W, X, Y, Z | |||
Ziprasidone |
Oral |
2015 Supplementary Cycle A |
|
Zolmitriptan |
Oral |
2015 Main Cycle |